A prognostic diagnostic marker claudin21 for ovarian cancer and its application
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- ZHEJIANG CANCER HOSPITAL
- Publication Date
- 2022-04-22
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The present invention belongs to the field of molecular biology, specifically relates to the field of diagnosis / grading / staging and prognosis of cancer, more specifically, the present invention relates to the field of ovarian cancer. The present invention also relates to the fields of ovarian cancer diagnosis, grading, staging and prognosis including the expression of biomarkers, and also provides related analytical reagents, diagnostic models, test kits and clinical analysis. Background technique
[0002] Ovarian cancer is the gynecological tumor with the highest mortality rate among women in my country. According to the China Cancer Annual Report, there were about 52,100 new patients in 2015, and about 22,500 people died of ovarian cancer in the same year. With the aging population in my country, the incidence of ovarian cancer is increasing year by year, and the age of onset tends to be younger. Globally, the incidence of ovarian cancer ranks third...